Progenitor (PGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Progenitor (PGEN)

PGEN 4.140

+2.2%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (33)	2/25/1998 5:21:00 PM
From: Czechsinthemail	Read Replies (1) of 106

Rick, Thanks for the links. One other item, concerning the potential value of PGEN. Lehman mentioned that major gene discoveries have added an average of $29 million in market capitalization. That would be better than a double for PGEN from here. My best guess is that the recent stock weakness is more related to selling of formerly restricted shares. Though it raises some intestinal butterflies, I'm not sure that such selling would be an indicator of substantial negatives. The AFFX/PGEN agreement looks like a very positive collaboration that realizes benefit for both companies with very little cost. I hope they can come up with more like it. PGEN's emphasis on stem cell research seems promising to me. Do you know of other genomic companies active in that area? Their focus on developmental biology seems a good way to optimize their research efforts and come up with promising leads. Given the low technology value and the high likelihood of positive announcements -- collaborations and discoveries -- I like the potential. Particularly at these prices. Baird

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next